Epigenetic Mechanisms in Breast Cancer Therapy and Resistance

Dr. Bhatnagar received her Ph.D. in Infectious diseases from the University of Notre Dame in 2007. She carried out her postdoctoral research with Dr. Michael R. Green at the University of Massachusetts Medical School in Worcester, MA. It was there that Dr. Bhatnagar began her work in understanding the epigenetic regulation of mammalian gene expression.Dr. Bhatnagar began her independent research career at the University of Virginia School of Medicine in 2015, where she was an Associate Professor in Biochemistry and Molecular Genetics. Recently, Dr. Bhatnagar joined the Medical Microbiology and Immunology department at University of California Davis. Dr. Bhatnagar’s research program focuses on (i) understanding epigenetic silencing mechanisms in the control of mammalian gene expression, (ii) investigate how these mechanisms are deployed during development, and (iii) identify critical steps that, when altered, disrupt normal function.

• Chapter 1 - MDIG in breast cancer progression and metastasis.- Chapter 2 - Tumor Microenvironment and Epigenetic Implications in Breast Cancer Progression.- Chapter 3 - The Epigenetic Landscape of Breast Cancer, Metabolism, and Obesity.- Chapter 4 - Epigenetic Modulations by Microbiome in Breast Cancer.- Chapter 5 - Facilitates chromatin transcription in breast and other cancers.- Chapter 6 - Advances in epigenetic therapeutics for breast cancer.- Chapter 7 - Detection methods for epigenetic mechanisms in breast cancer.